Transforming growth factor-β1 inhibits activation of macrophage cell line RAW 264.7 for cell killing
Open Access
- 1 November 1990
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 82 (2), 404-410
- https://doi.org/10.1111/j.1365-2249.1990.tb05461.x
Abstract
SUMMARY: Transforming growth factor β-1 (TGF-β) is a multi-potent immunoregulatory peptide that has effects on numerous cell types. Here we report that human TGF-β inhibits the activation of the macrophagc cell line RAW 264.7 for killing of the L1210 tumour cell line. RAW 264.7 cells, like normal macrophages, require sequential interaction with priming and triggering stimuli for full activation of cytolytic activity. TGF-β inhibits this cytotoxicity in a dose-dependent manner at both the priming and the triggering stage. Addition of as little as 1 ng/ml TGF-β when added with either the priming signal, recombinant interferon-gamma (IFN-γ), or the triggering signal, bacterial lipopolysaccharide (LPS), completely abrogated tumouricidal activity. Incubation with TGF-β also inhibited the morphological changes normally observed in activated RAW 264.7 cells. However. TGF-β was unable to inhibit the cytotoxic activity of RAW 264.7 cells against the target cell line WEHI 164, which is sensitive to tumour necrosis factor. In contrast to the effects on cytotoxic activity, the cytostatic activity of activated RAW 264.7 cells was not inhibited by TGF-β at doses of up to 5 ng/ml. In addition, pretreatment of the LI210 target cells with TGF-β made them refractory to both the cytostatic and cytotoxic effects of RAW 264.7 cells. These data suggest that TGF-β may be an important mediator in the regulation of macrophage tumouricidal activity.Keywords
This publication has 31 references indexed in Scilit:
- Interferon‐γ and tumor necrosis factor induce the L‐arginine‐dependent cytotoxic effector mechanism in murine macrophages*European Journal of Immunology, 1988
- Inhibition of the proliferative response of human B lymphocytes to B cell growth factor by transforming growth factor‐betaEuropean Journal of Immunology, 1988
- Beta transforming growth factors are potential regulators of B lymphopoiesis.The Journal of Experimental Medicine, 1987
- Inhibition of cytokine production by cyclosporin A and transforming growth factor beta.The Journal of Experimental Medicine, 1987
- Distribution and modulation of the cellular receptor for transforming growth factor-beta.The Journal of cell biology, 1987
- TGF-β inhibition of endothelial cell proliferation: Alteration of EGF binding and EGF-induced growth-regulatory (competence) gene expressionCell, 1987
- Transforming Growth Factor-β: Biological Function and Chemical StructureScience, 1986
- Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth.The Journal of Experimental Medicine, 1986
- Transforming growth factor-β controls receptor levels for epidermal growth factor in NRK fibroblastsCell, 1984
- Purification and properties of a type .beta. transforming growth factor from bovine kidneyBiochemistry, 1983